Primary Site >> Biliary tract Cancer
Gene >> CDH2
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. PMID: 8613003 |
Ref: N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. PMID: 18622386 |
Ref: Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression. PMID: 21423153 Ref: E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. PMID: 22068819 |
Ref: The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. PMID: 22406361 Ref: S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas. PMID: 22882148 Ref: Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma. PMID: 23091390 |
Ref: Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer. PMID: 23298711 Ref: Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis. PMID: 23919841 |
Ref: Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. PMID: 24406866 Ref: N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas. PMID: 24636838 Ref: EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. PMID: 24704591 Ref: BMP-7 blocks the effects of TGF-beta-induced EMT in cholangiocarcinoma. PMID: 24969562 Ref: Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray. PMID: 25077440 Ref: FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling. PMID: 25344679 |
Ref: Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis. PMID: 25744243 Ref: Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. PMID: 25854403 Ref: Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition. PMID: 26043778 |
Ref: A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer. PMID: 26726879 Ref: Distinct Clinicopathologic and Genetic Features of 2 Histologic Subtypes of Intrahepatic Cholangiocarcinoma. PMID: 27259014 Ref: Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma. PMID: 27280413 |
Ref: Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss. PMID: 27864835 Ref: The NmrA-like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial-mesenchymal transition. PMID: 28245089 Ref: Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- beta1-SMAD3-ID1 signaling pathway. PMID: 28611292 Ref: TGF-beta signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures. PMID: 28873435 Ref: C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis. PMID: 28945626 Ref: Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand. PMID: 29110582 Ref: Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. PMID: 29404445 |
Ref: Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma. PMID: 28608943 Ref: PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. PMID: 29358655 Ref: Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma. PMID: 29732001 Ref: [Kindlin-2 promotes gallbladder cancer metastasis and invasion by inducing epithelial-mesenchymal transition]. PMID: 30107706 Ref: EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma. PMID: 30349952 |